Drug Approval | October 23, 2023
Natco Pharma receives 8 observations from USFDA for Pharma Division at Kothur
The company is confident of addressing all the observations within the stipulated time
The company is confident of addressing all the observations within the stipulated time
RPG Life Sciences has reported total income of Rs. 155.41 crores during the period ended September 30, 2023
CB03 is a candidate drug for the treatment of ALS and other central nerve system (CNS) diseases
New Molecular biology lab launched, AIIA increased its work scope in form of MoUs
Investment is additive to KKR’s existing health care growth strategy
LG Chem is making progress in the development of the world's first oral treatment for rare forms of obesity.
Three-point improvement achieved in Sex Ratio at Birth from 904 in 2017-19 to 907 in 2018-20
The vaccine further advances Pfizer’s vaccine portfolio and builds on more than 20 years of expertise and knowledge in the prevention of meningococcal disease
Three block copolymers added to RESOMER portfolio of bioabsorbable polymers
Aarti Drugs has reported total income of Rs. 642.22 crores during the period ended September 30, 2023
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
